[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.29367246 [View]
File: 130 KB, 1236x617, gthx calls.png [View same] [iqdb] [saucenao] [google]
29367246

Anons, why do you hate money so much?
>no no no, I don't want to invest in undervalued stocks to get comfy gains. Let me lose everything gambling on memes!

Consider this: GTHX.

It's biopharmaceutical company that develops drug Cosela (trilaciclib). Cosela (trilaciclib) is the first therapy in its class to "reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer."

- helps to mitigate negative effects of chemotherapy
- breakthrough technology
- has no competition in the market
- potential blockbuster
- already approved by FDA
- is studied to help people with colorectal and breast cancer (1-3 phases in pipeline) which will dramatically increase its use. There are no problems so far.
- will eventually be approved internationally

Analysts set price targets from $38 to $78 with $60 average. Now it's ridiculously cheap, only $27. There is also a good chance it could be bought by big pharma for $60-90.

Puppetmaster manipulated the price after FDA approval to avoid exercising Feb Fri 19 call options with strike $25. Now there is nothing to keep the price this low. I was telling you to buy it at $25-26 before call options' expiration. It's still not too late.

I don't know what will happen tomorrow or even today but it's pretty low risk solid mid-long term play with x2-x4 potential. I am not sure if it will stay below $25 for long even in case of market correction. Maybe it makes sense to wait until main session though.

Navigation
View posts[+24][+48][+96]